Skip to main content
Premium Trial:

Request an Annual Quote

Christiane Honisch

Pathoquest announced today that it has appointed Christiane Honisch as an independent member of the firm's board of directors. With over 15 years of experience developing markers, assays, software, and technology for infectious disease detection, Honisch is currently head of global business intelligence and development at Eppendorf. Prior to Eppendorf, Honisch served as director of microbiology markets at Illumina. Before working at Illumina, Honisch served as director of infectious disease research at Roche Molecular Diagnostics.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.